Limula offers a modular and automated solution for on-demand and at-scale manufacturing of cell therapies.
Limula has raised $566K in total funding. The most recent round was Debt Financing. The last funding was announced in December 2024.
Limula's investors include European Innovation Council, LifeX Ventures, Verve Ventures, Zürcher Kantonal Bank, Venture Kick.
Limula is headquartered in La Tour-de-peilz, Switzerland.
Limula offers a modular and automated solution for on-demand and at-scale manufacturing of cell therapies.
Limula is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Limula — Funding & Investors." VCBacked, December 11, 2024, https://www.vcbacked.co/company/limula. Accessed July 19, 2026.
VCBacked. (2024). Limula — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/limula
{{cite web |title=Limula — Funding & Investors |url=https://www.vcbacked.co/company/limula |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated